216 related articles for article (PubMed ID: 19052760)
1. Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved.
Stenner M; Klussmann JP
Eur Arch Otorhinolaryngol; 2009 Mar; 266(3):333-41. PubMed ID: 19052760
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.
Felix A; El-Naggar AK; Press MF; Ordonez NG; Fonseca I; Tucker SL; Luna MA; Batsakis JG
Hum Pathol; 1996 Jun; 27(6):561-6. PubMed ID: 8666365
[TBL] [Abstract][Full Text] [Related]
3. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis.
Nagao T; Sugano I; Ishida Y; Asoh A; Munakata S; Yamazaki K; Konno A; Iwaya K; Shimizu T; Serizawa H; Ebihara Y
Mod Pathol; 2002 Jul; 15(7):724-33. PubMed ID: 12118110
[TBL] [Abstract][Full Text] [Related]
4. [New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].
Skálová A; Šteiner P; Vaneček T
Cesk Patol; 2016; 52(3):139-45. PubMed ID: 27526014
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-myoepithelial carcinomas.
Fonseca I; Soares J
Am J Clin Pathol; 1994 Feb; 101(2):242. PubMed ID: 7906920
[No Abstract] [Full Text] [Related]
6. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
[TBL] [Abstract][Full Text] [Related]
7. Translocation-associated salivary gland tumors: a review and update.
Weinreb I
Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307
[TBL] [Abstract][Full Text] [Related]
8. Polymorphous low-grade adenocarcinoma: flow cytometric, p53, and PCNA analysis.
Kelsch RD; Bhuiya T; Fuchs A; Gentile P; Kahn MA; Fantasia JE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):391-9. PubMed ID: 9347503
[TBL] [Abstract][Full Text] [Related]
9. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.
Luo W; Lindley SW; Lindley PH; Krempl GA; Seethala RR; Fung KM
Int J Clin Exp Pathol; 2014; 7(12):9008-22. PubMed ID: 25674280
[TBL] [Abstract][Full Text] [Related]
10. TP53 single nucleotide polymorphism rs1042522 in salivary gland neoplasms.
Gomes CC; Fonseca-Silva T; Diniz MG; Orsine LA; Gomez RS
Head Neck; 2014 Dec; 36(12):1685-8. PubMed ID: 24115240
[TBL] [Abstract][Full Text] [Related]
11. [p53 abnormality in salivary gland carcinoma and its relation to tumor DNA aneuploidy and AgNOR].
Suzuki T
Nihon Jibiinkoka Gakkai Kaiho; 1994 Dec; 97(12):2279-86. PubMed ID: 7861300
[TBL] [Abstract][Full Text] [Related]
12. Expression of the ERBB2 protein in benign and malignant salivary gland tumors.
Stenman G; Sandros J; Nordkvist A; Mark J; Sahlin P
Genes Chromosomes Cancer; 1991 Mar; 3(2):128-35. PubMed ID: 1676907
[TBL] [Abstract][Full Text] [Related]
13. Salivary Gland-Type Carcinomas of the Breast: A Review and Update With Emphasis on Molecular Advances and Differential Diagnosis.
Pesoli C; Youssef M; Wei S
Arch Pathol Lab Med; 2022 Nov; 146(11):1319-1328. PubMed ID: 35862856
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic and molecular genetic analysis of secretory carcinoma of salivary gland].
Zhao M; Zhao DH; Cheng G; Yan YJ; Wang Z; He XL
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Aug; 53(8):533-538. PubMed ID: 30078266
[No Abstract] [Full Text] [Related]
15. Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases.
da Cruz Perez DE; Pires FR; Alves FA; Almeida OP; Kowalski LP
Int J Pediatr Otorhinolaryngol; 2004 Jul; 68(7):895-902. PubMed ID: 15183580
[TBL] [Abstract][Full Text] [Related]
16. ras gene mutations in salivary gland tumors.
Yoo J; Robinson RA
Arch Pathol Lab Med; 2000 Jun; 124(6):836-9. PubMed ID: 10835516
[TBL] [Abstract][Full Text] [Related]
17. The role of HER2/neu, BCL2, p53 genes and proliferating cell nuclear protein as molecular prognostic parameters in localized prostate carcinoma.
Fonseca GN; Srougi M; Leite KR; Nesrallah LJ; Ortiz V
Sao Paulo Med J; 2004 May; 122(3):124-7. PubMed ID: 15448811
[TBL] [Abstract][Full Text] [Related]
18. [Mucoepidermoid carcinoma of salivary glands: the prognostic value of tumoral markers].
Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):482-8. PubMed ID: 17761202
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas.
Kishi M; Nakamura M; Nishimine M; Ikuta M; Kirita T; Konishi N
Oral Oncol; 2005 Feb; 41(2):161-9. PubMed ID: 15695118
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
